November 16, 2026 — The S&P 500 opened at 7,513.98 Monday morning, shedding 47.7 points, as the AI trade entered the most consequential week of its young maturity under a cloud that Jensen Huang left behind when he walked out of Nvidia’s Santa Clara headquarters for the last time.
Key takeaways
- The S&P 500 fell 0.63% to 7,513.98 at Monday’s open and the Nasdaq Composite dropped 1.13% to 24,853.35, with AI-linked stocks leading the decline.
- AMD opened down 8.75% to $534.06 on Monday, November 16, 2026, the steepest single-name loss among major semiconductor stocks at the bell.
- Novo Nordisk (NYSE: NVO) opened at $42.05 on November 16, 2026, rising roughly 1% after Phase 3 REDEFINE 9 trial data for CagriSema was presented at ObesityWeek 2026 in Washington, D.C.
The Weight of an Empty Chair
Jensen Huang’s resignation from the company he co-founded 33 years ago and built into a $4 trillion enterprise continues to reverberate across every corner of the semiconductor complex, and Monday’s open made clear that four trading sessions have not been enough to absorb the shock. The Dow Jones Industrial Average opened at 52,037.94, down 309.61 points or 0.59%. The Nasdaq Composite, home to the heaviest concentration of AI-exposed names, dropped 282.9 points, or 1.13%, to 24,853.35 at the bell — nearly double the S&P’s percentage decline. That gap tells you where the pain is concentrated.
The VIX opened the session at 20.59, up 6.7% from Friday’s close, according to pre-open data. That is not a panic reading, but it is a meaningful re-pricing of near-term uncertainty for a market that spent much of October in the low-to-mid teens on implied volatility. Options traders are paying up for downside protection into a week that packs Nvidia’s earnings report and Anthropic’s blockbuster IPO into a five-day window that was already loaded before Huang submitted his resignation. As we noted in our preview of this week’s catalysts, the sequencing alone created event risk that any one of three outcomes could resolve in conflicting directions.
The Chip Wreck Spreading Across the Tape
AMD led the damage at the open, falling 8.75% to $534.06, a move that far outpaced Nvidia’s own 2.01% decline to $162.85. That asymmetry is worth examining. AMD has no leadership crisis, no succession vacuum, no CFO-as-interim-CEO narrative. Its drop reflects something more systemic: the market is derating the entire category, not just the company at the center of the story. Broadcom fell 4.76% to $347.01. Micron dropped 2.52% to $778.31. CoreWeave slipped 6.4% and Nebius fell 7.8%. Data-center infrastructure plays including IREN, Applied Digital and Core Scientific each shed between 5% and 6% at the open.
The 10-year yield at 5.13% and the 30-year at 5.46% mean the rate backdrop offers no relief. As we flagged when CoreWeave reported, a sustained yield above 5% is not simply a headwind for speculative names — it actively compresses multiples across the growth spectrum. The 2-year yield at 4.85% suggests the front end remains sticky, limiting the Fed’s room to cut even if conditions deteriorate. For traders running long AI, the math of a 5.13% risk-free rate against earnings multiples that still reflect pre-resignation optimism does not resolve cleanly.
It is fair to ask whether AMD’s 8.75% single-session drop is an overreaction. The company reports its own earnings within the next two weeks, its competitive position in data-center GPU inference has not changed overnight, and its management team is intact. The market, however, is not trading AMD on AMD’s fundamentals today. It is trading AMD as a proxy for the AI trade’s collective confidence — and that confidence took a structural hit the moment Huang stepped away. The question we raised last Thursday — whether the AI trade can survive without its defining personality — is finding a preliminary answer at Monday’s open, and it is not encouraging.
The One Name Moving the Other Way
Novo Nordisk opened at $42.05, up roughly 1% from Friday’s close of $41.65, as Phase 3 REDEFINE 9 trial data for CagriSema landed at ObesityWeek 2026 in Washington, D.C. The Copenhagen-listed primary shares (NOVOb) gained approximately 2.7% to DKK 286.1. Cumulative volume in the ADR reached 6.3 million shares by approximately 10:10 AM ET, against a three-month average daily volume of 12.4 million — a pace that suggests elevated early-session engagement but not a stampede.
The NVO move is a triple catalyst in one session: new Phase 3 data, the ObesityWeek conference platform amplifying the results to a specialist audience, and a macro backdrop that is actively flushing capital out of AI and into defensive growth. Post-hoc analysis from REDEFINE 1 showed 25% mean weight loss among early responders, and Novo has already filed a New Drug Application with the FDA for CagriSema. That NDA status changes the nature of the trade from speculative pipeline bet to late-stage commercial anticipation. NVO’s 52-week range runs from $35.12 to $64.16, which means the stock is trading closer to its annual floor than its ceiling — a fact that cuts both ways depending on whether you read it as value or as evidence that the market has been persistently skeptical about execution after earlier disappointments.
What the First Hour Is Saying
The S&P 500’s intraday range through approximately 9:58 AM ET was 7,484.96 to 7,515.60, a band of roughly 30 points that reflects directionless selling pressure rather than a coordinated breakdown. The index opened at 7,513.98 against a previous close of 7,561.67 — a gap that pre-market futures had largely predicted. S&P 500 futures were showing 7,535.8, down 0.34%, before the open; the cash market opened weaker than futures implied, suggesting early sellers had more conviction than the overnight session captured.
The level to watch for the balance of the morning is 7,484.96 — the intraday low as of this writing. A clean break below that figure with volume would tell active traders that the opening dip is not being bought and that the downside scenario into Nvidia’s earnings is becoming consensus. A recovery back above 7,513.98, the opening print, would suggest stabilization and may draw in the first meaningful dip-buying of the session. Apple’s marginal gain of 0.39% to $356.27 and Microsoft’s 0.17% advance to $523.88 are worth monitoring as signals of whether mega-cap cash-flow names can decouple from the AI infrastructure selloff — if they hold, the broader index has a floor. If they roll over, there is nothing left to buy.
As our futures analysis noted earlier this morning, the Dow’s relative resilience — Dow futures were actually up 0.07% before the open — reflects the index’s lower AI concentration. That divergence between the Dow and Nasdaq is a useful real-time gauge of how much of today’s move is macro versus sector-specific. If the gap narrows as the morning progresses, the selling is broadening into something more systemic. If it persists, this is still, for now, an AI sector event wearing a market-wide mask. Last week’s pattern — chips absorb the damage while the broader tape holds — may be the template again. Or it may not. The week ahead will answer that.
Market mood: the PreMarket Sentiment Index stood at 26/100 (Risk-off) at the November 13, 2026 close.
Want our briefings first? Add PreMarket Daily as a preferred source on Google to see more of our coverage in Top Stories.
This article is published by PreMarket Daily for informational purposes only. Nothing here constitutes financial advice, investment recommendations, or an offer to buy or sell any securities. Always consult a qualified financial professional before making investment decisions.